Dr. Haikun Shi
Chief Clinical Drug Safety Expert, Senior Vice President, Clinical Service Center
Over 20 years of professional experience in clinical medicine and clinical drug safety research, at multinational pharmaceutical companies such as Roche in the U.S., Roche in Switzerland, and Express Scripts.
As a core member of various projects, participated in the clinical development of world-class drugs such as Avastin, Vemurafenib, Ocrelizumab, and Tagressa.
As a leading role in drug development, possessing experience in designing and guiding the implementation of research strategies, as well as conducting safety studies and monitoring for Phase I, II, and III clinical trials of oncology drugs.
Extensive experience in communication with regulatory authorities, including FDA, EMA, and NMPA, for IND and NDA submissions. Also, with rich experience in conducting clinical trial research in both China and USA.
